BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/22/2022 10:52:23 AM | Browse: 665 | Download: 1911
 |
Received |
|
2021-07-05 10:41 |
|
Peer-Review Started |
|
2021-07-05 10:47 |
|
First Decision by Editorial Office Director |
|
2021-11-11 08:36 |
|
Return for Revision |
|
2021-11-11 08:36 |
|
Revised |
|
2021-11-22 10:13 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-03-22 06:26 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-03-27 06:44 |
|
Articles in Press |
|
2022-03-27 06:44 |
|
Edit the Manuscript by Language Editor |
|
2022-03-18 12:52 |
|
Typeset the Manuscript |
|
2022-03-31 07:53 |
|
Publish the Manuscript Online |
|
2022-04-22 10:52 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Rasmus Hvidbjerg Gantzel, Mikkel Breinholt Kjær, Peter Jepsen, Niels Kristian Aagaard, Hugh Watson, Lise Lotte Gluud and Henning Grønbæk |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Henning Grønbæk, MD, PhD, Doctor, Doctor, Professor, Research Associate, Department of Hepatology and Gastroenterology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus N 8200, Denmark. henngroe@rm.dk |
| Key Words |
Atrial natriuretic peptide; B-type natriuretic peptide; Urodilatin; Cirrhosis; Ascites; Refractory ascites |
| Core Tip |
Pharmacotherapies for cirrhotic ascites have remained largely unchanged for the past four decades. 5%-10% of cirrhosis patients with ascites become refractory to available treatments, and the majority of these patients require frequent large-volume paracenteses. This justifies a continued search for new and improved treatments for ascites. This is the first systematic review and meta-analysis to investigate the effects and safety of natriuretic peptides as treatment of cirrhotic ascites. We demonstrate a significant natriuretic effect of intravenously administered atrial natriuretic peptide and summarise the safety findings. |
| Publish Date |
2022-04-22 10:52 |
| Citation |
Gantzel RH, Kjær MB, Jepsen P, Aagaard NK, Watson H, Gluud LL, Grønbæk H. Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis. World J Hepatol 2022; 14(4): 827-845 |
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i4/827.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i4.827 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
